Redox Laboratory
Our research is centered on investigating the metabolic alterations triggered by Reactive Oxygen and Nitrogen Species (RONS) in both solid tumors and blood-related cancers.
Currently, we are engaged in the validation and characterization of metabolic genes involved in heme, lipid, and amino acid pathways as potential targets for cancer therapy.
Furthermore, our laboratory is exploring the application of cold atmospheric plasma (4th state of matter), to develop innovative medical treatment strategies through precise delivery of RONS.
